相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Advances in the Current Treatment of Autoimmune Hepatitis
Albert J. Czaja
DIGESTIVE DISEASES AND SCIENCES (2012)
Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis
Harpreet K. Dhaliwal et al.
HEPATOLOGY (2012)
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes
A. M. C. Baven-Pronk et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis
Dermot Gleeson et al.
GUT (2011)
Mycophenolate for the treatment of autoimmune hepatitis: Prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients
Kalliopi Zachou et al.
JOURNAL OF HEPATOLOGY (2011)
Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease
A. Ansari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Diagnosis and Management of Autoimmune Hepatitis
Michael P. Manns et al.
HEPATOLOGY (2010)
The Pharmacogenetics of Calcineurin Inhibitor-Related Nephrotoxicity
Dennis A. Hesselink et al.
THERAPEUTIC DRUG MONITORING (2010)
Mycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis?
Elke M. Hennes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD
Nanne K. H. de Boer et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2007)
Cost-effectiveness of pharmacotherapy for autoimmune hepatitis
MA Heneghan et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine
MP Sparrow et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Differences in nucleotide hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods
M Shipkova et al.
CLINICAL CHEMISTRY (2003)
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2000)